Investigator Initiated Trials is a conference dedicated to opportunities within Investigator Initiated Trials for pharma companies and structured strategic plans for investment in any of these trials.
Investigator Initiated Trials covers topics such as:
- How to Interpret Clinical Trial Data and Investigator-Initiated Research Proposals to Redefine Safety and Effectiveness Information
- Investigator-Initiated Research Strategy for Data Insights and Clinical Research Expertise
- IIT Proposals in an Expedited and More Efficient Manner, While Staying Compliant
- Enhanced Standard Operating Procedures (SOPs) to Ensure Standardization of Study Procedures
- Engaging Knowledgeable and Experienced Researchers to Provide a Second Set of Eyes and Assure IIT Soundness and Feasibility
- Essential KOL Relationships and Thought Leader Management for Optimal Clinical Support
Investigator Initiated Trials brings together attendees involved or interested in:
- Investigator-Initiated Research and Studies (IIRS)
- Investigator-Initiated Trials (IIT), Research and Studies
- Medical Affairs
- Investigator Initiated Studies (IIS)
- Collaborative Studies
- MSLs/Medical Communication
- Scientific Engagement
- Research Grants
- External Operations & Sourcing
- Global Medical Research Operations
- Contract Administration
- Compliance, Legal and Regulatory
- Clinical Trial Monitoring/Management
- Clinical Trial Liaison
- Clinical Affairs
- Clinical Data Analysis
- Marketing Services
- Clinical Research
- Vendor Management
- Medical Clinical Operations
